Bayer's finerenone approved in India for heart failure
The expanded approval allows Kerendia to be prescribed to heart failure patients with a LVEF of 40% or more
The expanded approval allows Kerendia to be prescribed to heart failure patients with a LVEF of 40% or more
Quest Diagnostics’ blood-based test panels demonstrate confirmatory accuracy, potentially reducing the need for PET imaging
Telangana aims to increase the value of the Life Sciences economy from US$ 80 billion to US$ 250 billion by 2030
Long-term OGSIVEO treatment for up to four years associated with further tumor reductions, increased objective response rate, sustained symptom improvement, and consistent safety profile
These findings follow positive Phase 3 results presented earlier this year
The new plant will manufacture high-quality Type I borosilicate glass tubing
Phase 3 program for NDV-01 in non-muscle invasive bladder cancer expected to begin in the first half of 2026
ExellenS applies optimized facility designs, equipment, and processes across all sites to ensure equivalency and speed
Panacea Biotec receives Rs. 315 crore LoA from UNICEF
Subscribe To Our Newsletter & Stay Updated